{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:35:49Z","timestamp":1784543749810,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Traditional Chinese Medicine Science and Technology Project of Zhejiang Province, China","award":["2024ZL253"],"award-info":[{"award-number":["2024ZL253"]}]},{"name":"the Medicine and Health Science and Technology Project of Zhejiang Province, China","award":["2021KY475"],"award-info":[{"award-number":["2021KY475"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11675-y","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:48:15Z","timestamp":1760521695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The prevalence of Mycoplasma pneumoniae and study of co-infection with COVID-19 from a laboratory perspective, before and after the relaxation of COVID-19 control measures"],"prefix":"10.1186","volume":"25","author":[{"given":"Yan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wufeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"11675_CR1","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/S2666-5247(23)00344-0","volume":"5","author":"PM Meyer Sauteur","year":"2024","unstructured":"Meyer Sauteur PM, Beeton ML, European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Study group for Mycoplasma and chlamydia infections (ESGMAC), and the ESGMAC MP surveillance (MAPS) study group. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe. 2024;5:e100\u20131.","journal-title":"Lancet Microbe"},{"key":"11675_CR2","doi-asserted-by":"publisher","first-page":"854505","DOI":"10.3389\/fcimb.2022.854505","volume":"12","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Cheng Y, Dai S, Hou D, Ge M, Zhang Y, et al. The prevalence of Mycoplasma pneumoniae among children in Beijing before and during the COVID-19 pandemic. Front Cell Infect Microbiol. 2022;12:854505.","journal-title":"Front Cell Infect Microbiol"},{"key":"11675_CR3","doi-asserted-by":"publisher","first-page":"e0491122","DOI":"10.1128\/spectrum.04911-22","volume":"11","author":"L Li","year":"2023","unstructured":"Li L, Guo P, Ma J, Sun H, Mei S. Impact of COVID-19 on the epidemiological features of Mycoplasma pneumoniae infection in children with community-acquired pneumonia in Henan, China. Microbiol Spectr. 2023;11:e0491122.","journal-title":"Microbiol Spectr"},{"key":"11675_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12111623","author":"S Shin","year":"2023","unstructured":"Shin S, Koo S, Yang YJ, Lim HJ. Characteristics of the Mycoplasma pneumoniae epidemic from 2019 to 2020 in Korea: macrolide resistance and co-infection trends. Antibiotics. 2023. https:\/\/doi.org\/10.3390\/antibiotics12111623.","journal-title":"Antibiotics"},{"key":"11675_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2023.107480","volume":"221","author":"X Huang","year":"2024","unstructured":"Huang X, Gu H, Wu R, Chen L, Lv T, Jiang X, et al. Chest imaging classification in Mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes. Respir Med. 2024;221:107480.","journal-title":"Respir Med"},{"key":"11675_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/cid\/ciy419","volume":"68","author":"PK Kutty","year":"2019","unstructured":"Kutty PK, Jain S, Taylor TH, Bramley AM, Diaz MH, Ampofo K, et al. Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia. Clin Infect Dis. 2019;68:5\u201312.","journal-title":"Clin Infect Dis"},{"key":"11675_CR7","volume":"3","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Shan Y, Cui Y, Shi J, Wang F, Miao H, et al. Characteristics and outcome of severe Mycoplasma pneumoniae pneumonia admitted to PICU in Shanghai: a retrospective cohort study. Crit Care Explor. 2021;3:e0366.","journal-title":"Crit Care Explor"},{"key":"11675_CR8","doi-asserted-by":"publisher","first-page":"e22213","DOI":"10.1016\/j.heliyon.2023.e22213","volume":"9","author":"J Ma","year":"2023","unstructured":"Ma J, Guo P, Mei S, Li M, Yu Z, Zhang Y, et al. Influence of COVID-19 pandemic on the epidemiology of Mycoplasma pneumoniae infections among hospitalized children in Henan, China. Heliyon. 2023;9:e22213.","journal-title":"Heliyon"},{"key":"11675_CR9","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1080\/22221751.2022.2078228","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang X, Li M, Luo M, Luo Q, Kang L, Xie H, et al. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020. Emerg Microbes Infect. 2022;11:1508\u201317.","journal-title":"Emerg Microbes Infect"},{"key":"11675_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","volume":"30","author":"KB Waites","year":"2017","unstructured":"Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30:747\u2013809.","journal-title":"Clin Microbiol Rev"},{"key":"11675_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12887-021-02679-z","volume":"21","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Huang Y, Ai T, Luo J, Liu H. Effect of COVID-19 on childhood Mycoplasma pneumoniae infection in Chengdu, China. BMC Pediatr. 2021;21:202.","journal-title":"BMC Pediatr"},{"key":"11675_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab416","volume":"8","author":"TH Wu","year":"2021","unstructured":"Wu TH, Wang NM, Liu FC, Pan HH, Huang FL, Fang YP, et al. Macrolide resistance, clinical features, and cytokine profiles in Taiwanese children with Mycoplasma pneumoniae infection. Open Forum Infect Dis. 2021;8:ofab416.","journal-title":"Open Forum Infect Dis"},{"key":"11675_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.13005\/bbra\/3081","volume":"20","author":"MK Ali","year":"2023","unstructured":"Ali MK, Khan DI, Mittal A, Khan S, Akhtar S. Prevalence and clinical spectrum of Mycoplasma pneumoniae in community-acquired pneumonia. Biosci Biotech Res Asia. 2023;20:197\u2013209.","journal-title":"Biosci Biotech Res Asia"},{"key":"11675_CR14","doi-asserted-by":"publisher","DOI":"10.2807\/ese.17.06.20081-en","volume":"17","author":"V Chalker","year":"2012","unstructured":"Chalker V, Stocki T, Litt D, Bermingham A, Watson J, Fleming D, et al. Increased detection of Mycoplasma pneumoniae infection in children in England and wales, october 2011 to january 2012. Euro Surveill. 2012;17:20081.","journal-title":"Euro Surveill"},{"key":"11675_CR15","doi-asserted-by":"publisher","DOI":"10.2807\/ese.17.10.20110-en","volume":"17","author":"NJ Gadsby","year":"2012","unstructured":"Gadsby NJ, Reynolds AJ, McMenamin J, Gunson RN, McDonagh S, Molyneaux PJ, et al. Increased reports of Mycoplasma pneumoniae from laboratories in Scotland in 2010 and 2011 - impact of the epidemic in infants. Euro Surveill. 2012;17:20110.","journal-title":"Euro Surveill"},{"key":"11675_CR16","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/ijd.15090","volume":"59","author":"J Monte Serrano","year":"2020","unstructured":"Monte Serrano J, Garc\u00eda-Gil MF, Crua\u00f1es Monferrer J, Aldea Manrique B, Prieto-Torres L, Garc\u00eda Garc\u00eda M, et al. COVID-19 and Mycoplasma pneumoniae: SARS-CoV-2 false positive or coinfection? Int J Dermatol. 2020;59:1282\u20133.","journal-title":"Int J Dermatol"},{"key":"11675_CR17","doi-asserted-by":"publisher","first-page":"e763","DOI":"10.1016\/S2666-5247(23)00182-9","volume":"4","author":"PM Meyer Sauteur","year":"2023","unstructured":"Meyer Sauteur PM, Beeton ML. ESGMAC the ESGMAC MAPS study group. Mycoplasma pneumoniae: gone forever? Lancet Microbe. 2023;4:e763.","journal-title":"Lancet Microbe"},{"key":"11675_CR18","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1017\/S0950268818000778","volume":"146","author":"X Zhang","year":"2018","unstructured":"Zhang X, Chen Z, Gu W, Ji W, Wang Y, Hao C, et al. Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia. Epidemiol Infect. 2018;146:1384\u20138.","journal-title":"Epidemiol Infect"},{"key":"11675_CR19","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/j.jinf.2020.07.010","volume":"81","author":"L Zha","year":"2020","unstructured":"Zha L, Shen J, Tefsen B, Wang Y, Lu W, Xu Q. Clinical features and outcomes of adult COVID-19 patients co-infected with Mycoplasma pneumoniae. J Infect. 2020;81:e12-5.","journal-title":"J Infect"},{"key":"11675_CR20","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.4103\/lungindia.lungindia_607_20","volume":"38","author":"A Choubey","year":"2021","unstructured":"Choubey A, Sagar D, Cawley P, Miller K. Retrospective review analysis of COVID-19 patients co-infected with Mycoplasma pneumoniae. Lung India. 2021;38:S22\u20136.","journal-title":"Lung India"},{"issue":"10","key":"11675_CR21","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1002\/jmv.26026","volume":"92","author":"V Gayam","year":"2020","unstructured":"Gayam V, Konala VM, Naramala S, Garlapati PR, Merghani MA, Regmi N, et al. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA. J Med Virol. 2020;92(10):2181\u20137.","journal-title":"J Med Virol"},{"key":"11675_CR22","first-page":"537","volume":"56","author":"JL Che-Morales","year":"2019","unstructured":"Che-Morales JL, Cortes-Telles A. \u00cdndice neutr\u00f3filo\/linfocito Como Biomarcador S\u00e9rico Asociado Con neumon\u00eda adquirida En Comunidad [Neutrophil-to-lymphocyte ratio as a serum biomarker associated with community acquired pneumonia]. Rev Med Inst Mex Seguro Soc. 2019;56:537\u201343.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"11675_CR23","doi-asserted-by":"publisher","unstructured":"Cui FF, Tian XJ, Xin DL, Han XH, Wang LY, Dou Haiwei et al. Pneumonia characteristics of hospitalized children infected with Macrolide-Resistant Mycoplasma pneumoniae. Res Square. 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-675299\/v1","DOI":"10.21203\/rs.3.rs-675299\/v1"},{"key":"11675_CR24","unstructured":"Jin Y, Xu YD, Yang YH, Lai YY. The clinical significance of changes of leukocyte and C-Reactive protein in children after acute infection by Mycoplasma pneumoniae. Prog Mod Biomed. 2011. https:\/\/www.semanticscholar.org\/paper\/The-Clinical-Significance-of-Changes-of-Leukocyte-Yu-yao\/910210776175e5305ab0490595f952bbe4147fe2"},{"key":"11675_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12026-019-09096-6","volume":"67","author":"Z Wang","year":"2019","unstructured":"Wang Z, Yang L, Ye J, Wang Y, Liu Y. Monocyte subsets study in children with Mycoplasma pneumoniae pneumonia. Immunol Res. 2019;67:373\u201381.","journal-title":"Immunol Res"},{"key":"11675_CR26","doi-asserted-by":"publisher","unstructured":"Yao S, Xie Y, Chen F, Chen X, Zhang M, Li Y. The value of neutrophil\/monocyte ratio in early diagnosis of children Mycoplasma pneumoniae pneumonia. Res Square. 2020 https:\/\/doi.org\/10.21203\/rs.3.rs-64768\/v1","DOI":"10.21203\/rs.3.rs-64768\/v1"},{"key":"11675_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0002-9343(93)90087-6","volume":"94","author":"G Shor-Posner","year":"1993","unstructured":"Shor-Posner G, Basit A, Lu Y, Cabrejos C, Chang J, Fletcher M, et al. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med. 1993;94:515\u20139.","journal-title":"Am J Med"},{"key":"11675_CR28","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1371\/journal.pbio.0040365","volume":"4","author":"Z Mujawar","year":"2006","unstructured":"Mujawar Z, Rose H, Morrow MP, Pushkarsky T, Dubrovsky L, Mukhamedova N, et al. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006;4:e365.","journal-title":"PLoS Biol"},{"key":"11675_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cca.2020.07.015","volume":"510","author":"X Hu","year":"2020","unstructured":"Hu X, Chen D, Wu L, He G, Ye W. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta. 2020;510:105\u201310.","journal-title":"Clin Chim Acta"},{"key":"11675_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23911","volume":"35","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Yang Y, Fan L, Ye S, Lou K, Hua X, et al. Low serum level of Apolipoprotein A1 may predict the severity of COVID-19: a retrospective study. J Clin Lab Anal. 2021;35:e23911.","journal-title":"J Clin Lab Anal"},{"key":"11675_CR31","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/jcm11040964","volume":"11","author":"N Miyashita","year":"2022","unstructured":"Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ishiura Y, et al. Clinical differences between Community-Acquired Mycoplasma pneumoniae pneumonia and COVID-19 pneumonia. J Clin Med. 2022;11:964.","journal-title":"J Clin Med"},{"key":"11675_CR32","unstructured":"Zhi-Yun Z, Laboratory DO. Analysis on clinical examination of 150 children with Mycoplasma pneumoniae infection. Guide China Med. 2024. https:\/\/www.semanticscholar.org\/paper\/Analysis-on-Clinical-Examination-of-150-Children-Zhi-yu\/0293e3b69ceed2723aea7fd330acd809c8d59f95"},{"issue":"2","key":"11675_CR33","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/jmv.26467","volume":"93","author":"D Amin","year":"2021","unstructured":"Amin D, McKitish K, Shah PS. Association of mortality and recent Mycoplasma pneumoniae infection in COVID-19 patients. J Med Virol. 2021;93(2):1180\u20133.","journal-title":"J Med Virol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11675-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11675-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11675-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:48:19Z","timestamp":1760521699000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11675-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11675"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11675-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1328"}}